ATRC.NASDAQAtricure, INC

Form 4: AtriCure CEO Michael Carrel Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


AtriCure's CEO, Michael Carrel, reports acquisition and disposal of company stock, including shares from restricted stock and performance share awards.

Summary

  • Michael Carrel, CEO of AtriCure, reported transactions involving AtriCure common stock on March 1, 2024.
  • He acquired 50,854 shares through a restricted stock award and 69,142 shares through the vesting of a performance share award.
  • Carrel also disposed of 47,824 shares to cover tax withholding obligations at a price of $36.28 per share.
  • Following these transactions, Carrel directly owns 657,532 shares of AtriCure common stock.
  • He also indirectly owns 3,310 shares held by his children and 2,250 shares held by his parents, but disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of performance shares indicates the company met its goals, while the stock disposal is a routine tax-related transaction. The CEO maintains a significant stake in the company.

Positives

  • The vesting of performance share awards suggests that the company met its performance goals.
  • The acquisition of shares through restricted stock awards aligns the CEO's interests with the company's long-term performance.

Negatives

  • The disposal of shares to cover tax obligations, while common, slightly reduces the CEO's direct stake in the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to track management's sentiment and alignment with company performance.

Comparison to Industry Standards

  • Stock awards and vesting schedules are common compensation practices among publicly traded companies, particularly in the technology and healthcare sectors.
  • Companies like Medtronic and Boston Scientific also utilize stock-based compensation to align executive incentives with shareholder value.
  • The vesting schedule of one-third annually is a typical vesting structure for restricted stock awards.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding executive compensation and ownership.
  • The vesting of performance shares may positively impact employee morale.

Key Dates

DateDescription
03/01/2024Date of stock transactions (acquisition and disposal).
03/05/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.